{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:01:38Z","timestamp":1761541298109,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.brachy.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T03:46:08Z","timestamp":1450755968000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage\u00a0I\u2013II endometrial cancer: A monoinstitutional experience"],"prefix":"10.1016","volume":"15","author":[{"given":"Elisabetta","family":"Perrucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mariucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Saccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2015.10.010_bib1","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0020-7292(12)60024-1","article-title":"Cancer of the corpus uteri","volume":"119","author":"Amant","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2015.10.010_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1634\/theoncologist.2013-0475","article-title":"Adjuvant therapy in early-stage endometrial cancer: A systematic review of the evidence, guidelines, and clinical practice in the U S","volume":"19","author":"Latif","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.brachy.2015.10.010_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomized trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2015.10.010_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2015.10.010_bib6","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.10.010_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority,\u00a0randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2015.10.010_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2014.12.036","article-title":"The role of vaginal cuff brachytherapy in endometrial cancer","volume":"136","author":"Harkenrider","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunnemann","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2015.10.010_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canrad.2012.12.008","volume":"17","author":"Charra-Brunaud","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2015.10.010_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1748-717X-6-164","article-title":"Endometrial cancer\u2014reduce to the minimum. A new paradigm for adjuvant treatments?","volume":"6","author":"Scheithauer","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2015.10.010_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.10.010_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: Results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: A systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2005.04.030","article-title":"Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors","volume":"98","author":"Rittenberg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2009.06.027","article-title":"Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation","volume":"116","author":"McCloskey","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.10.010_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1998.5155","article-title":"Adjuvant vaginal high-dose rate-afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy","volume":"71","author":"Weiss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00066-011-0004-0","article-title":"Current therapy of patients with endometrial carcinoma. A critical review","volume":"188","author":"Marnitz","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2015.10.010_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A\u00a0randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2015.10.010_bib23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2015.10.010_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2010.07.003","article-title":"Lymph nodes: Is total number or station number a better predictor of lymph node metastasis in endometrial cancer?","volume":"119","author":"Huang","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ygyno.2014.03.554","article-title":"Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer","volume":"133","author":"Dunn","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2015.10.010_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2014.08.038","article-title":"Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with imaged-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification","volume":"113","author":"Vargo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.10.010_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib30","doi-asserted-by":"crossref","first-page":"20120428","DOI":"10.1259\/bjr.20120428","article-title":"Vaginal vault brachytherapy in endometrial cancer: Verifying target coverage with image-guided applicator placement","volume":"86","author":"Humprey","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2015.10.010_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brachy.2007.03.005","article-title":"An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer","volume":"6","author":"Barney","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.10.010_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.prro.2012.12.005","article-title":"Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?","volume":"4","author":"Zou","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2015.10.010_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brachy.2010.10.005","article-title":"Should the organs at risk be contoured in vaginal cuff brachytherapy?","volume":"10","author":"Holloway","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.10.010_bib34","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.ijrobp.2011.11.029","article-title":"Comparison of 2D and 3D imaging and treatment planning for postoperative vaginal apex high-dose rate brachytherapy for endometrial cancer","volume":"83","author":"Russo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.10.010_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2014.11.022","article-title":"Nomograms for prediction of outcome with or without adjuvant radiation therapy for\u00a0patients with endometrial cancer: A pooled analysis of PORTEC-1 and PORTEC-2 trials","volume":"91","author":"Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115005747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115005747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:09:51Z","timestamp":1761530991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472115005747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1538472115005747"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2015.10.010","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage\u00a0I\u2013II endometrial cancer: A monoinstitutional experience","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}